• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Nvidia Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

    5/30/23 1:27:22 PM ET
    $AAIC
    $ACON
    $AI
    $AINC
    Real Estate Investment Trusts
    Real Estate
    Medical Specialities
    Health Care
    Get the next $AAIC alert in real time by email

    Gainers

    • QualTek Services Inc. (NASDAQ:QTEK) shares jumped 127.2% to $0.1740 after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter 11 bankruptcy.
    • T2 Biosystems, Inc. (NASDAQ:TTOO) shares climbed 99.4% to $0.1886 after the company reported second largest sepsis-driven instrument sale in company history.
    • Aclarion, Inc. (NASDAQ:ACON) climbed 69% to $1.0430 after the company announced a commercial agreement with the London Clinic and London Spine Clinic
    • Arlington Asset Investment Corp. (NASDAQ:AAIC) shares gained 50.1% to $4.1285 after Ellington Financial announced plans to acquire the company.
    • GreenLight Biosciences Holdings (NASDAQ:GRNA) rose 37.8% to $0.2750 after the company announced it entered into a definitive agreement to be acquired by a group of buyers led by Fall Line Capital in an all-cash transaction valuing the company at approximately $45.5 million.
    • Equitrans Midstream Corporation (NYSE:ETRN) gained 37.4% to $8.35 after RBC Capital upgraded the stock from Sector Perform to Outperform and raised its price target from $7 to $10.
    • GD Culture Group Limited (NASDAQ:GDC) gained 31.3% to $5.83.
    • Atento S.A. (NYSE:ATTO) shares surged 30.6% to $1.91 after gaining 8% on Friday.
    • Monopar Therapeutics Inc. (NASDAQ:MNPR) rose 30% to $1.1726.
    • Babylon Holdings Limited (NASDAQ:BBLN) surged 25.6% to $0.66.
    • PyroGenesis Canada Inc. (NASDAQ:PYR) gained 24.6% to $0.8328.
    • Ideanomics, Inc. (NASDAQ:IDEX) rose 22.6% to $0.0466.
    • Taro Pharmaceutical Industries Ltd. (NYSE:TARO) surged 22.5% to $36.01.
    • Fanhua Inc. (NASDAQ:FANH) climbed 18.8% to $7.69 following first-quarter results.
    • Ashford Inc. (NYSE:AINC) rose 17.6% to $10.89.
    • Virios Therapeutics, Inc. (NASDAQ:VIRI) gained 17.4% to $1.69. Virios Therapeutics recently regained compliance with Nasdaq minimum bid price requirement.
    • mCloud Technologies Corp. (NASDAQ:MCLD) jumped 14.6% to $0.6150. mCloud Technologies recently formed a special committee for the purpose of exploring strategic alternatives.
    • Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) rose 14.5% to $8.65 after the company reported the FDA acceptance of the Biologics License Application of lifileucel for the treatment of advanced melanoma.
    • UP Fintech Holding Limited (NASDAQ:TIGR) gained 13% to $2.9250 following better-than-expected quarterly results.
    • C3.ai, Inc. (NYSE:AI) shares climbed 12.3% to $37.03. The stock appears to be moving in anticipation of the company's quarterly results, which are due after the close Wednesday.
    • Riot Platforms, Inc. (NASDAQ:RIOT) gained 12.3% to $12.26.
    • ChargePoint Holdings, Inc. (NASDAQ:CHPT) climbed 12.2% to $9.52 after B of A Securities upgraded the stock from Neutral to Buy.
    • Wearable Devices Ltd. (NASDAQ:WLDS) shares rose 11.3% to $1.3020 after dropping 17% on Friday. Wearable Devices recently announced its Mudra Band for Apple Watch is available for preorder.
    • Kingsoft Cloud Holdings Limited (NASDAQ:KC) gained 11% to $4.2050. Kingsoft Cloud recently said first-quarter FY23 earnings missed estimates.
    • Nexters Inc. (NASDAQ:GDEV) climbed 9.9% to $7.50.
    • United Homes Group, Inc. (NASDAQ:UHG) rose 9.9% to $11.50.
    • Coinbase Global, Inc. (NASDAQ:COIN) gained 8% to $61.46 after Atlantic Equities upgraded the stock from Neutral to Overweight and announced a $70 price target.
    • Broadcom Inc. (NASDAQ:AVGO) climbed 6.7% to $867.42. Several analysts, including, Keybanc, Evercore ISI Group and BMO Capital raised their price targets on the stock.
    • NVIDIA Corporation (NASDAQ:NVDA) gained 5.3% to $409.94 after the company announced it would build the Israel-1 generative AI cloud supercomputer. The stock is also trading higher on continued upward AI momentum following the company's Q1 results.

    Losers

    • Smart for Life, Inc. (NASDAQ:SMFL) shares fell 36.6% to $1.3750. Smart for Life reported exercise of warrants for $4.5 million in gross proceeds.
    • Applied UV, Inc. (NASDAQ:AUVI) dropped 33% to $0.3751. Applied UV reported a 1-for-5 reverse stock split.
    • SeqLL Inc. (NASDAQ:SQL) fell 26.8% to $0.38. SeqLL entered into definitive merger agreement with Lyneer Staffing Solutions and Atlantic Acquisition Corp.
    • D-Wave Quantum Inc. (NYSE:QBTS) dropped 21.5% to $1.3105.
    • Oncorus, Inc. (NASDAQ:ONCR) fell 20.4% to $0.1750 after jumping 10% on Friday. Oncorus recently posted a narrower-than-expected quarterly loss.
    • Bright Health Group, Inc. (NASDAQ:BHG) fell 18.3% to $9.61. RBC Capital maintained Bright Health with a Sector Perform and lowered the price target from $80 to $13.
    • Beamr Imaging Ltd. (NASDAQ:BMR) dropped 17.3% to $3.34.
    • Unique Fabricating, Inc. (NASDAQ:UFAB) dropped 16.8% to $0.2108.
    • Presto Automation Inc. (NASDAQ:PRST) fell 16.7% to $2.99 after jumping 64% on Friday. Presto Automation recently entered into commitments for an $10 million common equity pipe.
    • TScan Therapeutics, Inc. (NASDAQ:TCRX) shares fell 16.5% to $2.6646 after jumping 31% on Friday. TScan Therapeutics raised $140 million via secondary stock offering of 23 million at $2 per share and 47 million pre-funded warrants at $2 per share.
    • 9 Meters Biopharma, Inc. (NASDAQ:NMTR) dropped 16.2% to $0.6708. 9 Meters Biopharma announced management change and issued a clinical update on vurolenatide in patients with short bowel syndrome.
    • Enveric Biosciences, Inc. (NASDAQ:ENVB) dropped 15.5% to $3.6472.
    • Allarity Therapeutics, Inc. (NASDAQ:ALLR) fell 14.7% to $0.2670 after declining 9% on Friday.
    • Appreciate Holdings, Inc. (NASDAQ:SFR) shares dropped 11.7% to $0.2820 after jumping around 60% on Friday.
    • IronNet, Inc. (NYSE:IRNT) shares dropped 11.4% to $0.2320 after climbing 33% on Friday. IronNet 13G Filing showed 3i, LP increased stake in the company to 9.99%.
    • Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) dipped 10.6% to $4.18. Atea Pharmaceuticals' board unanimously rejected unsolicited proposal from Tang Capital Partners' Affiliate, Concentra Biosciences.
    • HUTCHMED (China) Limited (NASDAQ:HCM) fell 9.9% to $12.06.
    • Seelos Therapeutics, Inc. (NASDAQ:SEEL) fell 9.3% to $0.8419. On May 23, Nasdaq provided notice to Seelos Therapeutics that it has not regained compliance with rule 5550(A)(2).
    • Sana Biotechnology, Inc. (NASDAQ:SANA) dropped 9% to $5.72.
    • Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) shares declined 8.3% to $2.9150. Lexicon Pharmaceuticals reported the FDA approval of INPEFA for the treatment of heart failure..
    • Weibo Corporation (NASDAQ:WB) fell 8.2% to $14.03.
    • Skyline Champion Corporation (NYSE:SKY) dropped 7.6% to $59.61 after the company reported mixed Q4 financial results.
    • Comerica Incorporated (NYSE:CMA) fell 6.8% to $36.34.

    Now Read This: Top 5 Health Care Stocks That Could Blast Off In May

    Get the next $AAIC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAIC
    $ACON
    $AI
    $AINC

    CompanyDatePrice TargetRatingAnalyst
    C3.ai Inc.
    $AI
    2/26/2026Mkt Outperform → Mkt Perform
    Citizens
    Iovance Biotherapeutics Inc.
    $IOVA
    2/25/2026$5.00Mkt Perform → Mkt Outperform
    Citizens
    Broadcom Inc.
    $AVGO
    2/13/2026$335.00Neutral
    DA Davidson
    Coinbase Global Inc.
    $COIN
    2/12/2026$120.00Buy → Neutral
    Monness Crespi & Hardt
    D-Wave Quantum Inc.
    $QBTS
    2/12/2026Buy
    TD Cowen
    Kingsoft Cloud Holdings Limited
    $KC
    2/11/2026$15.60Neutral → Buy
    Goldman
    Broadcom Inc.
    $AVGO
    1/30/2026$400.00Peer Perform → Outperform
    Wolfe Research
    Coinbase Global Inc.
    $COIN
    1/28/2026$240.00Neutral
    Robert W. Baird
    More analyst ratings

    $AAIC
    $ACON
    $AI
    $AINC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    C3.ai downgraded by Citizens

    Citizens downgraded C3.ai from Mkt Outperform to Mkt Perform

    2/26/26 7:10:22 AM ET
    $AI
    Computer Software: Prepackaged Software
    Technology

    Iovance Biotherapeutics upgraded by Citizens with a new price target

    Citizens upgraded Iovance Biotherapeutics from Mkt Perform to Mkt Outperform and set a new price target of $5.00

    2/25/26 7:38:09 AM ET
    $IOVA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    DA Davidson initiated coverage on Broadcom with a new price target

    DA Davidson initiated coverage of Broadcom with a rating of Neutral and set a new price target of $335.00

    2/13/26 8:31:21 AM ET
    $AVGO
    Semiconductors
    Technology

    $AAIC
    $ACON
    $AI
    $AINC
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    February 16, 2024 - FDA Approves First Cellular Therapy to Treat Patients with Unresectable or Metastatic Melanoma

    For Immediate Release: February 16, 2024 Today, the U.S. Food and Drug Administration approved Amtagvi, the first cellular therapy indicated for the treatment of adult patients with a type of skin cancer (melanoma) that is unable to be removed with surgery (unresectable) or has spread to other parts of the body (metastatic) that previously has been treated with other therapies (a PD-1 blocking antibody, and if B

    2/16/24 3:48:47 PM ET
    $IOVA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for INPEFA issued to LEXICON PHARMACEUTICALS INC

    Submission status for LEXICON PHARMACEUTICALS INC's drug INPEFA (ORIG-1) with active ingredient SOTAGLIFLOZIN has changed to 'Approval' on 05/26/2023. Application Category: NDA, Application Number: 216203, Application Classification: Type 1 - New Molecular Entity

    5/30/23 10:02:49 AM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAIC
    $ACON
    $AI
    $AINC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Debbane Raymond bought $2,980 worth of shares (2,000 units at $1.49), increasing direct ownership by 0.11% to 1,906,186 units (SEC Form 4)

    4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)

    2/27/26 8:33:21 AM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Debbane Raymond bought $147,000 worth of shares (100,000 units at $1.47), increasing direct ownership by 6% to 1,904,186 units (SEC Form 4)

    4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)

    2/25/26 7:00:27 AM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Debbane Raymond bought $219,755 worth of shares (150,000 units at $1.47), increasing direct ownership by 9% to 1,804,186 units (SEC Form 4)

    4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)

    2/23/26 7:49:43 AM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAIC
    $ACON
    $AI
    $AINC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    NVIDIA and Global Telecom Leaders Commit to Build 6G on Open and Secure AI-Native Platforms

    News Summary: Leading operators and infrastructure providers including Booz Allen, BT Group, Cisco, Deutsche Telekom, Ericsson, MITRE, Nokia, ODC, SK Telecom, SoftBank Corp. and T-Mobile will build on open and trusted software-defined wireless platforms.The commitment complements NVIDIA's ongoing collaborations with industry and governments across Europe, Japan, Korea, the U.K. and the U.S. to advance AI-native 6G innovation. BARCELONA, Spain, March 01, 2026 (GLOBE NEWSWIRE) -- Mobile World Congress—NVIDIA today announced a commitment — together with Booz Allen, BT Group, Cisco, Deutsche Telekom, Ericsson, MITRE, Nokia, OCUDU Ecosystem Foundation, ODC, SK Telecom, SoftBank Corp. and T-Mo

    3/1/26 2:00:00 AM ET
    $NVDA
    Semiconductors
    Technology

    Beamr Issues Annual CEO Letter to Shareholders: From Validation to Execution in AI Video

    In 2026, Beamr plans to build the foundations of its long-term growth by further developing solutions for video data in AI systems - both for human viewers and for machine vision Herzliya, Israel, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Beamr Imaging Ltd. (NASDAQ:BMR), a leader in video optimization technology and solutions, today issued a Letter to Shareholders from Sharon Carmel, Chief Executive Officer. Dear Shareholders: As we enter 2026, I am pleased to share with you our key achievements last year and update you on our strategy to drive future growth. 2025 was a year of meaningful progress for Beamr as we validated our technology for the autonomous vehicle (AV) sector, strengthened our

    2/26/26 4:10:00 PM ET
    $BMR
    Computer Software: Prepackaged Software
    Technology

    Quantum Computing Acceleration is Unlocking New Era of Autonomous Drone Efficiency

    NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - Quantum computing is starting to play a meaningful role in improving how drones operate, especially when it comes to planning and real-time decision-making. Drone missions involve thousands of moving parts — weather, airspace rules, terrain, battery life, payload weight, and changing objectives. Traditional computers process these variables step by step, which can slow things down as operations scale. Quantum computing, however, is designed to evaluate many possibilities at once, helping operators find faster, more efficient routes and better mission plans. For investors, that means lower operating costs, fas

    2/26/26 9:45:00 AM ET
    $IONQ
    $QBTS
    $QUBT
    EDP Services
    Technology
    Computer Software: Prepackaged Software

    $AAIC
    $ACON
    $AI
    $AINC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Debbane Raymond bought $2,980 worth of shares (2,000 units at $1.49), increasing direct ownership by 0.11% to 1,906,186 units (SEC Form 4)

    4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)

    2/27/26 8:33:21 AM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Iovance Biotherapeutics Inc.

    4 - IOVANCE BIOTHERAPEUTICS, INC. (0001425205) (Issuer)

    2/26/26 5:00:18 PM ET
    $IOVA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Chief Accounting Officer Jones Jennifer N. sold $170,122 worth of shares (1,102 units at $154.38), closing all direct ownership in the company (SEC Form 4)

    4 - Coinbase Global, Inc. (0001679788) (Issuer)

    2/26/26 4:14:47 PM ET
    $COIN
    Finance: Consumer Services
    Finance

    $AAIC
    $ACON
    $AI
    $AINC
    SEC Filings

    View All

    SEC Form 10-K filed by D-Wave Quantum Inc.

    10-K - D-Wave Quantum Inc. (0001907982) (Filer)

    2/26/26 4:13:29 PM ET
    $QBTS
    EDP Services
    Technology

    SEC Form 6-K filed by Beamr Imaging Ltd.

    6-K - Beamr Imaging Ltd. (0001899005) (Filer)

    2/26/26 4:11:11 PM ET
    $BMR
    Computer Software: Prepackaged Software
    Technology

    SEC Form 20-F filed by Beamr Imaging Ltd.

    20-F - Beamr Imaging Ltd. (0001899005) (Filer)

    2/26/26 4:07:12 PM ET
    $BMR
    Computer Software: Prepackaged Software
    Technology

    $AAIC
    $ACON
    $AI
    $AINC
    Leadership Updates

    Live Leadership Updates

    View All

    ChargePoint Appoints Jaser Faruq Chief Product and Software Officer

    ChargePoint (NYSE:CHPT), a global leader in electric vehicle (EV) charging solutions, today announced the appointment of industry veteran Jaser Faruq as Chief Product and Software Officer. In this role, Faruq will lead ChargePoint's global product management and software development teams, bringing to market revolutionary new hardware and software solutions for the future of eMobility. Faruq brings considerable experience to ChargePoint, most recently at Schneider Electric. While there, Faruq led the company's North American electrification businesses, overseeing EV chargers, batteries, and smart panels. Simultaneously, Faruq managed several acquisitions, including that of the energy mark

    2/23/26 4:15:00 PM ET
    $CHPT
    Industrial Specialties
    Consumer Discretionary

    D-Wave Joins Southeastern Quantum Collaborative as Inaugural Member

    D-Wave Quantum Inc. (NYSE:QBTS) ("D-Wave" or the "Company"), the only dual-platform quantum computing company, providing both annealing and gate-model systems, software and services, today joined the Southeastern Quantum Collaborative (SQC) as an inaugural member, along with The University of Alabama in Huntsville, Davidson Technologies, IBM and Alabama A&M University. The SQC will bring together academia, industry and government to accelerate the advancement and application of quantum information science and technology across the Southeast. In addition, it aims to develop the quantum-ready workforce needed to commercialize the technology. Given Davidson hosts a D-Wave Advantage2TM system

    2/19/26 7:00:00 AM ET
    $QBTS
    EDP Services
    Technology

    Sana Biotechnology Appoints Brian Piper as Executive Vice President, Chief Financial Officer

    SEATTLE, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ:SANA), a company focused on changing the possible for patients through engineered cells, today announced the appointment of Brian Piper as Executive Vice President, Chief Financial Officer. Mr. Piper brings to Sana a breadth of biopharmaceutical financial and operational expertise with over 25 years of experience in various positions in the industry. Mr. Piper was most recently CFO of Scorpion Therapeutics and its post-acquisition spin-off, Antares Therapeutics. "I am thrilled to welcome Brian to Sana and to our leadership team," said Steve Harr, President and Chief Executive Officer of Sana. "He brings deep exper

    2/17/26 9:00:00 AM ET
    $SANA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AAIC
    $ACON
    $AI
    $AINC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by United Homes Group Inc

    SC 13G - United Homes Group, Inc. (0001830188) (Subject)

    12/17/24 5:44:48 PM ET
    $UHG
    Homebuilding
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Monopar Therapeutics Inc.

    SC 13D/A - Monopar Therapeutics (0001645469) (Subject)

    12/17/24 5:01:42 PM ET
    $MNPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by United Homes Group Inc

    SC 13D/A - United Homes Group, Inc. (0001830188) (Subject)

    12/13/24 6:24:20 PM ET
    $UHG
    Homebuilding
    Consumer Discretionary

    $AAIC
    $ACON
    $AI
    $AINC
    Financials

    Live finance-specific insights

    View All

    Lexicon Pharmaceuticals to Report Fourth Quarter 2025 Financial Results on March 5, 2026

    THE WOODLANDS, Texas, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) today announced the Company will release its fourth quarter 2025 financial results on Thursday, March 5, 2026, prior to market open. Management will conduct a conference call and live webcast at 8:30 a.m. ET (7:30 a.m. CT) that day to discuss the financial results and to provide a business update. Participants can access the conference call live via webcast on the Events page of the Company's website at https://investors.lexpharma.com/. Participants who wish to ask a question may register here to receive dial-in numbers and a unique pin to join the call. An archived version of the webcast w

    2/26/26 8:30:00 AM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    D-Wave Reports Fourth Quarter and Year-End 2025 Results

    FY 2025 Revenue Increased 179% Year over Year FY 2025 Gross Profit Increased 265% Year over Year Ended 2025 With Highest Liquidity Position in Company's History at over $884 Million D-Wave Quantum Inc. (NYSE:QBTS) ("D-Wave" or the "Company"), the only dual-platform quantum computing company, providing both annealing and gate-model systems, software, and services, today announced financial results for its fiscal fourth quarter and year ended December 31, 2025. "Our 2025 results mark one of the most successful and transformative years in D-Wave's history, with meaningful growth across every key business metric — revenue, Bookings, technical milestones, and scientific breakthroughs," s

    2/26/26 7:00:00 AM ET
    $QBTS
    EDP Services
    Technology

    Atea Pharmaceuticals to Host Fourth Quarter and Full Year 2025 Financial Results and Business Update Conference Call on March 5, 2026

    BOSTON, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) (Atea or Company), a late-stage clinical biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced that it will host a live conference call and audio webcast on Thursday, March 5, 2026, at 4:30 p.m. ET to report financial results for the fourth quarter and full year ended December 31, 2025, and to provide a business update. To access the live conference call, participants may register here. The live audio webcast of the call will be available under "Events and Presentations" in the Investor Relations section of the Atea Phar

    2/26/26 7:00:00 AM ET
    $AVIR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAIC
    $ACON
    $AI
    $AINC
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    What Does the Recent Purchase at Monopar Therapeutics Inc. on Jun 21 Indicate?

    Monopar Therapeutics Inc. has recently seen notable insider activity, with Chief Operating Officer Cittadine Andrew purchasing $25,574 worth of shares on June 21st, 2024. This purchase, comprising 32,508 units at $0.79, increased Cittadine's direct ownership by 21% to 186,132 units as reported in the SEC Form 4. When analyzing this transaction alongside other recent insider activities within the company, interesting patterns and trends start to emerge. Looking back, Cittadine Andrew has been consistently adding to his position in Monopar Therapeutics Inc. over the past few months, showcasing a strong conviction in the company's future prospects. On May 31st, Cittadine Andrew made a substan

    6/22/24 8:00:00 PM ET
    $MNPR
    Biotechnology: Pharmaceutical Preparations
    Health Care